Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Mosaic ImmunoEngineering Inc. (CPMV) had Debt to Capital Ratio of -0.24 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-0.69M |
|
-- |
|
-- |
|
$0.62M |
|
$-0.62M |
|
$-0.07M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.62M |
|
$-0.62M |
|
7.24M |
|
7.24M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$0.02M |
|
-- |
|
-- |
|
$0.02M |
|
$6.03M |
|
$1.47M |
|
$1.47M |
|
$7.50M |
|
$-7.48M |
|
$-7.48M |
|
$-7.48M |
|
7.24M |
|
| Cash Flow Statement Financials | |
$-0.11M |
|
-- |
|
-- |
|
$0.12M |
|
$0.00M |
|
$-0.11M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-0.24 |
-0.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
9.20% |
|
9.20% |
|
-3459.64% |
|
11.44% |
|
$-1.03 |
|
$-0.02 |
|
$-0.02 |
|